Table 3

The neuropathologically investigated group - diagnoses and individual levels of CSF markers
Case Aβ42 (ng/L) Tau (ng/L) P-tau (ng/L) NFL (ng/L) Clinical diagnosis Neuropathological diagnosis Degeneration severity Dementia duration at LP (years) Age at death (years) Brain weight (g)
1 726 819 NA 5546 FTD FTD-TDP43 moderate 2 54 1020
2 570 410 35 3770 FTD-MND FTD-TDP43 mild 0.4 62 1600
3 420 620 NA 2600 bvFTD FTD-FUS severe 3 37 NK
4 500 450 54 1620 bvFTD FTD-TDP43 severe NK 67 1340
5 662 494 NA 1494 bvFTD FTD-FUS severe 3 34 NK
6 411 263 NA 1241 FTD(PPA) FTD-TDP43 severe 12 76 975
7 370 330 29 1050 FTD(PPA) FTD-TDP43 severe 5 69 760
8 780 490 68 1030 bvFTD FTD-tau mild 4 81 1125
9 369 554 95 665 FTD(PPA) FTD-tau severe 7 73 1010
10 639 528 NA <250 AD FTD-tau mild NK 53 1335

PPA Primary progressive aphasia.

NA Not analysed.

NK Not known.

Landqvist Waldö et al.

Landqvist Waldö et al. BMC Neurology 2013 13:54   doi:10.1186/1471-2377-13-54

Open Data